The retrieved chunks don't directly address seed fundraising strategy for UK healthtech founders. They show what founders did *after* raising seed (Healthy.io's 600k round [#325], Unlearn.ai's path to a $12m Series A [#111], Scalpel's clinical trials during seed [Ep 38]) and mention that UK seed rounds are notably smaller than US equivalents [#226], but they don't cover the mechanics of *how* to raise one: investor targeting, pitch strategy, proof points, timeline, or the specific UK fundraising environment.
Ask instead: "What proof points do UK healthtech founders need before approaching seed investors?" or "How has UK healthtech funding changed in the last three years?" The archive likely addresses both.
Search 450+ episodes and 42,000 chunks of healthtech conversation.